Developement Science – | Precision (Individualized) Dosing

Precision (Individualized) Dosing

arrow

Balancing the benefits and risks of therapies is critical. A key to achieving this balance is identifying the dose at which efficacy is maximized and toxicity and adverse events is minimized.

Precision(Individualized) dosing is a next generation dosing paradigm in which our Clinical Pharmacology group is using mathematical models for drugs and diseases, in combination with individual patient demographics (e.g. genotype, organ function, body-weight), disease characteristics (e.g. drug target expression, pathogen susceptibility, disease activity) and measured drug concentration and response to treatment, to calculate the optimal dose for each patient.

Model-informed precision dosing allows integration of all available knowledge on a drug in a mathematical model and to use this to inform individual treatment in order to increase efficacy and decrease safety issues. Model-informed precision dosing may become standard of care for certain drugs with narrow therapeutic index by use of companion dosing tools.

Target Biomarker based dosing

In some cases, since the drug target varies over a large range in patients, we need to personalize the dosing based on patient weight and baseline target level in that patient.

XOLAIR (omalizumab)

arrow
Close Bitnami banner